U.S. Markets close in 2 hrs 5 mins

Keryx Biopharma: 1Q Earnings Snapshot

BOSTON (AP) _ Keryx Biopharmaceuticals Inc. (KERX) on Thursday reported a loss of $21.9 million in its first quarter.

The Boston-based company said it had a loss of 18 cents per share.

The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 19 cents per share.

The biopharmaceutical company posted revenue of $21.8 million in the period.

Keryx Biopharma shares have climbed 11 percent since the beginning of the year. The stock has declined 26 percent in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KERX at https://www.zacks.com/ap/KERX